1. Home
  2. AKTX vs LSB Comparison

AKTX vs LSB Comparison

Compare AKTX & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKTX
  • LSB
  • Stock Information
  • Founded
  • AKTX N/A
  • LSB 2002
  • Country
  • AKTX United States
  • LSB China
  • Employees
  • AKTX N/A
  • LSB N/A
  • Industry
  • AKTX Biotechnology: Pharmaceutical Preparations
  • LSB
  • Sector
  • AKTX Health Care
  • LSB
  • Exchange
  • AKTX Nasdaq
  • LSB NYSE
  • Market Cap
  • AKTX 29.1M
  • LSB 31.5M
  • IPO Year
  • AKTX N/A
  • LSB N/A
  • Fundamental
  • Price
  • AKTX $1.45
  • LSB $1.33
  • Analyst Decision
  • AKTX
  • LSB
  • Analyst Count
  • AKTX 0
  • LSB 0
  • Target Price
  • AKTX N/A
  • LSB N/A
  • AVG Volume (30 Days)
  • AKTX 28.2K
  • LSB 26.5K
  • Earning Date
  • AKTX 04-16-2025
  • LSB 06-21-2025
  • Dividend Yield
  • AKTX N/A
  • LSB N/A
  • EPS Growth
  • AKTX N/A
  • LSB N/A
  • EPS
  • AKTX N/A
  • LSB N/A
  • Revenue
  • AKTX N/A
  • LSB $79,415,311.00
  • Revenue This Year
  • AKTX N/A
  • LSB $39.33
  • Revenue Next Year
  • AKTX N/A
  • LSB $75.61
  • P/E Ratio
  • AKTX N/A
  • LSB N/A
  • Revenue Growth
  • AKTX N/A
  • LSB N/A
  • 52 Week Low
  • AKTX $0.85
  • LSB $1.26
  • 52 Week High
  • AKTX $4.40
  • LSB $11.20
  • Technical
  • Relative Strength Index (RSI)
  • AKTX 64.05
  • LSB 30.77
  • Support Level
  • AKTX $1.03
  • LSB $1.26
  • Resistance Level
  • AKTX $1.58
  • LSB $1.79
  • Average True Range (ATR)
  • AKTX 0.16
  • LSB 0.23
  • MACD
  • AKTX 0.02
  • LSB -0.06
  • Stochastic Oscillator
  • AKTX 77.72
  • LSB 6.00

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

About LSB LAKESHORE BIOPHARMA CO LTD

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: